Baird Maintains Neutral on Oscar Health, Raises Price Target to $19

Benzinga Newsdesk www.benzinga.com Neutral 63.7%

Neg 0% Neu 63.7% Pos 0%

Baird analyst Michael Ha maintains Oscar Health (NYSE:OSCR) with a Neutral and raises the price target from $15 to $19.

Comments

No comments yet. Be the first!